510(k) Report

510(k) · Cleared

Cleared

Nuvasive Spherx II System

K091502510(k) SpecialCleared Jul 22, 200962-day reviewClass II21 CFR 888.3070

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nuvasive, Inc. · NKB Thoracolumbosacral Pedicle Screw System

Cleared on Jul 22, 2009 as substantially equivalent to K061778 (Nuvasive, Inc., 2006) after a 62-day review. Its family tree reaches back 1 generation to 2006. 153 later devices descend from it.

Decided
Jul 22, 2009
Review
62 days
Class
Class II
Product code
NKB
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K061778 (2006). 153 later devices descend from it, 5 citing it directly.

Descendants, by year cleared 2011: 2 descendants cleared2015: 8 descendants cleared2009: 1 descendant cleared2013: 5 descendants cleared2010: 2 descendants cleared2012: 3 descendants cleared2018: 11 descendants cleared2014: 7 descendants cleared2016: 10 descendants cleared2017: 6 descendants cleared2023: 23 descendants cleared2021: 10 descendants cleared2025: 12 descendants cleared2026: 14 descendants cleared2022: 9 descendants cleared2019: 6 descendants cleared2020: 9 descendants cleared2024: 15 descendants clearedK061778 · Nuvasive Spherx II System · Nuvasive, Inc. · 200620052010201520202025
Descendants, by generation 1 generation forward: 5 descendants2 generations forward: 21 descendants3 generations forward: 25 descendants4 generations forward: 31 descendants5 generations forward: 25 descendants6 generations forward: 27 descendants7 generations forward: 15 descendants8 generations forward: 4 descendants K061778 · Nuvasive Spherx II System · Nuvasive, Inc. · 20060+5
  1. Root · 1 generation backK061778 Nuvasive Spherx II SystemNuvasive, Inc. · 2006
  2. This deviceK091502 Nuvasive Spherx II SystemNuvasive, Inc. · 2009
  3. Descendant · cites it directly · 82 of its ownK132014 GSB Global Spinal Balance SystemNuvasive, Inc. · 2013
  4. Descendant · 2 generations on · 78 of its ownK142499 Reline SystemNu Vasive, Incorporated · 2014
  5. Descendant · cites it directly · 77 of its ownK143684 NuVasive Reline SystemNu Vasive, Incorporated · 2015
  6. Descendant · cites it directly · 72 of its ownK092287 Nuvasive Spherx II - Pedicle Screw SystemNuvasive, Inc. · 2009
  7. Descendant · 2 generations on · 67 of its ownK160989 NuVasive® Reline® SystemNu Vasive, Incorporated · 2016

Showing 5 of 153 descendants. See all descendants

Descendants cleared per year

2009: 12010: 22011: 22012: 32013: 52014: 72015: 82016: 102017: 62018: 112019: 62020: 92021: 102022: 92023: 232024: 152025: 122026: 14
2009high 23 (2023) · low 1 (2009)2026

Most influential descendants

Showing 5 of 153 · See all
  • K132014GSB Global Spinal Balance SystemNuvasive, Inc. · 2013 · cites it directly82descendants
  • K142499Reline SystemNu Vasive, Incorporated · 2014 · 2 generations on78descendants
  • K143684NuVasive Reline SystemNu Vasive, Incorporated · 2015 · cites it directly77descendants
  • K092287Nuvasive Spherx II - Pedicle Screw SystemNuvasive, Inc. · 2009 · cites it directly72descendants
  • K160989NuVasive® Reline® SystemNu Vasive, Incorporated · 2016 · 2 generations on67descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K061778Nuvasive Spherx II SystemNuvasive, Inc.2006—
0 (this device)K091502Nuvasive Spherx II SystemNuvasive, Inc.2009—
+1K132014GSB Global Spinal Balance SystemNuvasive, Inc.2013—
+2K142499Reline SystemNu Vasive, Incorporated2014—
+1K143684NuVasive Reline SystemNu Vasive, Incorporated2015—
+1K092287Nuvasive Spherx II - Pedicle Screw SystemNuvasive, Inc.2009—
+2K160989NuVasive® Reline® SystemNu Vasive, Incorporated2016—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201020
201120
201230
201350
201470
201580
2016100
201760
2018110
201960
202090
2021100
202290
2023230
2024150
2025120
2026140
FIG. 1 — Lineage of K091502, 2006–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NKB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NKB device

  1. #1 K223494 CD Horizon Spinal Systemscore 40.4 · 30 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061778Nuvasive Spherx II System
Summary page 1
…NKB, KWP, MNI, MNH, KWQ C. Predicate Devices The subject SpheRx II -Pedicle Screw System is substantially equivalent to the SpheRx II System (K061778) currently distributed commercially in the U.S. by NuVasive. D. Device Description The Nu Vasive SpheRx II -Pedicle Sc…
Nuvasive, Inc.2006—

Also cleared against K061778: 2 other devices →

What descends from it? (153)

See all 153

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K132014GSB Global Spinal Balance SystemNuvasive, Inc.201382
K143684NuVasive Reline SystemNu Vasive, Incorporated201577
K092287Nuvasive Spherx II - Pedicle Screw SystemNuvasive, Inc.200972
K102514Nuvasive Spherx II -Mas Deformity Spinal SystemNuvasive, Inc.201013
K111410Nuvasive Long Lateral Spinal SystemNuvasive, Inc.20111

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K132014 (Nuvasive, Inc., 2013) has gone furthest, with 82 descendants of its own.
  • 2 other devices also cite its predicate K061778.

How does its category compare?

All NKB devices

NKB Thoracolumbosacral Pedicle Screw System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · NKB

24in 2025

2007: 382008: 362009: 442010: 372011: 482012: 602013: 352014: 462015: 552016: 502017: 632018: 562019: 392020: 482021: 322022: 342023: 442024: 392025: 242026 (partial year): 30
2007high 63 (2017) · low 24 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NKB

61in 2025

2007: 87 days median2008: 59 days median2009: 71 days median2010: 111 days median2011: 84 days median2012: 79 days median2013: 73 days median2014: 90 days median2015: 90 days median2016: 84 days median2017: 69 days median2018: 61 days median2019: 84 days median2020: 68 days median2021: 61 days median2022: 88 days median2023: 72 days median2024: 57 days median2025: 61 days median2026 (partial year): 91 days median
2007high 111 (2010) · low 57 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NKB

1in 2025

2007: 42008: 52009: 332010: 42011: 32012: 132014: 3, 1 Class I2015: 32016: 12017: 12018: 32019: 12020: 12022: 52023: 22024: 32025: 12026 (partial year): 3
2007high 33 (2009) · low 0 (2013)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · NKB

1,171in 2025

2007: 342008: 822009: 1712010: 4622011: 5772012: 1,7472013: 1,9622014: 1,6712015: 1,4462016: 1,5852017: 1,6182018: 1,6842019: 1,9152020: 2,0762021: 1,7452022: 1,3392023: 9192024: 1,6142025: 1,171
2007high 2,076 (2020) · low 34 (2007)2025

MAUDE reports naming product code NKB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20073887434
20083659582
2009447133171
2010371114462
201148843577
20126079131,747
2013357301,962
201446903 (1)1,671
2015559031,446
2016508411,585
2017636911,618
2018566131,684
2019398411,915
2020486812,076
2021326101,745
2022348851,339
202344722919
2024395731,614
2025246111,171
202630913—

What is it indicated for?

When used as a pedicle screw fixation system, the NuVasive SpheRx Spinal System is intended provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the posteriorto thoracic, lumbar, and sacral spine: 1. Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed…

Read the full statement (229 words)

When used as a pedicle screw fixation system, the NuVasive SpheRx Spinal System is intended provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the posteriorto thoracic, lumbar, and sacral spine:

1. Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies)

2. Degenerative spondylolisthesis with objective evidence of neurologic impairment

3. Fracture

4. Dislocation

5. Scoliosis

6. Kyphosis

7. Spinal tumor and/or

8. Failed previous fusion (pseudoarthrosis)

The NuVasive SpheRx Spinal System is also indicated for the treatment of severe spondylolisthesis (Grades 3 and 4) of the L5-S1 vertebral joint in skeletally mature patients receiving fusion by autogenous bone graft, having the device fixed or attached to the lumbar and sacral spine (L3 to sacrum), removal of the implants after attainment of a solid fusion. with

When used as an anterolateral non-pedicle screw system inthe thoracic and lumbar spine, the NuVasive SpheRx Spinal System is also intended for the following indications:

1. Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies)

2. Spinal stenosis

3. Spondylolisthesis

4. Spinal deformities

5. Fracture

6. Pseudoarthosis

7. Tumor resection and/or

8. Failed previous fusion

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K091502: Nuvasive Spherx II System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K091502

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026